Celularity
(NASDAQ) CELU
Celularity Financials at a Glance
Market Cap
$35.18M
Revenue (TTM)
$40.58M
Net Income (TTM)
$80.64M
EPS (TTM)
$-3.33
P/E Ratio
-0.37
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Price
$1.21
Volume
925
Open
$1.25
Price
$1.21
Volume
925
Open
$1.25
Previous Close
$1.21
Daily Range
$1.20 - $1.25
52-Week Range
$1.01 - $4.35
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Price
$1.21
Volume
925
Open
$1.25
Previous Close
$1.21
Daily Range
$1.20 - $1.25
52-Week Range
$1.01 - $4.35
CELU News
CELU: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Celularity
Industry
Biotechnology
Sector
Health CareEmployees
123
CEO
Robert Joseph Hariri Gordon, MD, PhD
Website
www.celularity.comHeadquarters
Florham Park, NJ 07932, US
CELU Financials
Key Financial Metrics (TTM)
Gross Margin
55%
Operating Margin
-1%
Net Income Margin
-2%
Return on Equity
-6367%
Return on Capital
-99%
Return on Assets
-71%
Earnings Yield
-2.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$35.18M
Shares Outstanding
28.84M
Volume
925
Short Interest
0.00%
Avg. Volume
167.76K
Financials (TTM)
Gross Profit
$39.23M
Operating Income
$38.36M
EBITDA
$43.71M
Operating Cash Flow
$6.40M
Capital Expenditure
$161.00K
Free Cash Flow
$6.56M
Cash & ST Invst.
$738.00K
Total Debt
$68.84M
Celularity Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.28M
-43.2%
Gross Profit
$3.27M
-39.7%
Gross Margin
61.81%
N/A
Market Cap
$35.18M
N/A
Market Cap/Employee
$293.18K
N/A
Employees
120
N/A
Net Income
$23.07M
-43.3%
EBITDA
$19.73M
-58.5%
Quarterly Fundamentals
Net Cash
$66.64M
+3.3%
Accounts Receivable
$6.71M
-23.5%
Inventory
$2.56M
-35.3%
Long Term Debt
$61.04M
+130.8%
Short Term Debt
$5.72M
-86.6%
Return on Assets
-70.59%
N/A
Return on Invested Capital
-99.19%
N/A
Free Cash Flow
$4.16M
-2223.5%
Operating Cash Flow
$4.16M
-2788.2%